
Founded in 1993, IDG Capital is a leading private equity investment firm headquartered in Hong Kong, recognized for its global vision and long-standing market presence. Over the past three decades, we have built a truly global investment platform with strong connectivity across key markets. Our seasoned team combines first-hand market insight with a global perspective, leveraging an extensive network of industry resources and strategic partners. We invest across consumer technology, healthcare, and consumer sectors, partnering with exceptional companies throughout their growth journey and supporting their international expansion.
The order this company entered each market — oldest to newest
Managing Director
Sign up to see the full signal feed
How IDG Capital's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
IDG CapitalYou | 0 | 0 | 0% | 0 | 32 |
Executive-in-Training Program (Fund Assistant Track)
View postingHong Kong SAR · last wk.
Finance Manager
View postingHong Kong, Hong Kong SAR · last yr.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
METiS TechBio, an AI-powered drug delivery company, successfully listed on HKEX, raising over HKD 2.1 billion with 18 cornerstone investors including BlackRock.
Ripple valued at $15B by CBInsights, ranking 23rd globally. XRP shows signs of recovery amid market stagnation, with technical indicators suggesting potential upward momentum.
Two Chinese companies successfully challenged US blacklisting, highlighting Washington's lack of legitimacy in suppressing global competitors through unilateral political means.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about IDG Capital's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.